MHRA announces Good Clinical Practice (GCP) Discussion Forum
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
The U.K. Medicines and Healthcare products Regulatory Agency MHRA has created a GCP Discussion Forum to help all those involved in the conduct of clinical trials implement quality procedures that can ensure compliance with clinical trials legislation and GCP requirements.
The platform also provides the ideal opportunity for an extended communication between researchers and allows users to put forward their comments and get 'real-life' examples.
Related GMP News
16.04.2026EMA Guidance on Conducting Clinical Trials during Public Health Emergencies
16.04.2026EMA accelerates Development of Medicines
16.04.2026What are the GMP Requirements for Drug Development?
26.03.2026FDA Guidance on Statistical Methods for Clinical Trials
26.03.2026Final ICH M11 CeSHarP Guideline
24.02.2026Good AI Practice in Drug Development